Search This Blog

Tuesday, November 5, 2019

Akcea Therapeutics EPS beats by $0.19, misses on revenue

Akcea Therapeutics (NASDAQ:AKCA): Q3 GAAP EPS of -$0.34 beats by $0.19.
Revenue of $20.62M (+7.2% Y/Y) misses by $1.92M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)